Tango Therapeutics Inc.（TNGX）今日盘中大涨5.10%，引起了市场的广泛关注。
消息面上，Tango Therapeutics与生物制药公司Erasca, Inc.宣布建立临床合作，将共同开展针对ERAS-0015与vopimetostat联合疗法的临床评估。这一合作旨在探索两种创新疗法联用的潜力，为患者提供更有效的治疗选择，并有望加速创新疗法的开发进程，从而提振了投资者信心。
双方计划通过临床研究验证联合方案的协同效应，重点关注其在特定适应症中的安全性与疗效。这一合作标志着两家公司在肿瘤治疗领域迈出的重要一步，可能为Tango Therapeutics带来长期增长机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.